Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cipla Ltd. Regulatory Filings 2020

Jun 12, 2020

59275_rns_2020-06-12_6d585b92-2343-48a7-9ba8-fd59e8d541da.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

12th June, 2020

  • (1) BSE Ltd Listing Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
  • (2) National Stock Exchange of India Ltd Listing Department Exchange Plaza, 5th floor, Plot no. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087

Scrip Code: CIPLA

(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Disclosure of related party transactions for the half year ended 31st March, 2020

Dear Sir/Madam,

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards, for the half year ended 31st March, 2020.

This disclosure is also being uploaded on the website of the Company i.e. www.cipla.com.

This is for your information and record.

Thanking you,

Yours faithfully, For Cipla Limited

Rajendra Chopra Company Secretary

Prepared by: Pratiksha Mangaonkar

Consolidated disclosure of related party transaction and balances for the half yearly ended 31st March, 2020

Information on related party transactions as required by Ind AS-24 - 'Related Party Disclosures' are given below:

List of related parties

A. Associate

Stempeutics Research Private Limited Avenue Therapeutics, Inc. Brandmed (Pty) Ltd (w.e.f. 24th April, 2019) AMPSolar Power Systems Private Limited (w.e.f. 12th June, 2019)

B. Key management personnel

Ms. Samina Hamied - Executive Vice-Chairperson Mr. Umang Vohra – Managing Director and Global Chief Executive Officer Mr. Kedar Updhaye - Global Chief Financial Officer Dr. Raghunathan Ananthanarayanan - President and Global Chief Operating Officer (Upto 31st December, 2019)

C. Non executive chairman and non executive vice chairman

Dr. Y. K. Hamied, Chairman Mr. M. K. Hamied, Vice Chairman

D. Non executive directors

Mr. Ashok Sinha Mr. Adil Zainulbhai Ms. Punita Lal Ms. Naina Lal Kidwai Mr. Peter Lankau (Upto 30th June,2019) Dr. Peter Mugyenyi Mr. S Radhakrishnan

E. Entities over which key management personnel are able to exercise significant influence

Cipla Foundation Chest Research Foundation (Formerly known as Hamied Foundation upto 14th October, 2019) Cipla Cancer and AIDS Foundation

F. Trust over which entity has control/significant influence

Cipla Limited Employees Provident Fund Cipla Limited Employees Gratuity Fund Cipla Employees Stock Option Trust Cipla Health Employees Stock Option Trust

₹ Crore
Particulars For the half year ended
31st March, 2020
A. Remuneration (Including sitting fees)*
Dr. Y.K. Hamied 1.02
Mr. M.K. Hamied 1.04
Ms. Samina Hamied 3.39
Mr. Umang Vohra 7.82
Mr. S.Radhakrishnan 1.04
Mr. Kedar Upadhye 1.91
Mr. Ashok Sinha 0.24
Mr. Adil Zainulbhai 0.24
Ms. Punita Lal 0.20
Ms. Naina Lal Kidwai 0.23
Dr. Peter Mugyenyi 0.26
Dr. Raghunathan Ananthanarayanan (6.69)
10.70

* Expenses towards gratuity, compensated absences and premium paid for group health insurance has not been considered in above information as a separate actuarial valuation/premium paid are not available.

B. Testing and analysis charges paid
Stempeutics Research Private Limited 1.08
1.08
C. Freight charges paid
Stempeutics Research Private Limited 0.02
0.02
D. Contribution to provident fund and other fund
Cipla Limited Employees Gratuity Fund 15.00
Cipla Limited Employees Provident Fund 20.39
20.39
E. Donations given
Cipla Foundation 19.08
Chest Research Foundation 2.00
21.08
F. Rent received
Dr. Y.K. Hamied (₹ 10,020/-) 0.00
0.00
G. Reimbursement of operating/other expenses
Stempeutics Research Private Limited 0.27
0.27
H. Equity Investment made during the period
AMPSolar Power Systems Private Limited 0.09
0.09
I. Investment in compulsory convertible debentures 8.91
AMPSolar Power Systems Private Limited
8.91
₹ Crore
Particulars For the half year ended
31st March, 2020
J. Payable to key management personnel and non executive directors
Dr. Y.K. Hamied 2.00
Mr. M.K. Hamied 2.00
Ms. Samina Hamied 2.30
Mr. Umang Vohra 4.00
Mr. S.Radhakrishnan 2.00
Mr. Kedar Upadhye 0.90
Mr. Ashok Sinha 0.40
Mr. Adil Zainulbhai 0.36
Ms. Punita Lal 0.35
Ms. Naina Lal Kidwai 0.35
Mr. Peter Lankau 0.10
Dr. Peter Mugyenyi 0.41
15.17
K. Contribution payable to provident fund
Cipla Employees Provident Fund 10.37
10.37
L. Payable to gratuity fund
Cipla Limited Employees Gratuity Fund 27.94
27.94
M. Dividend paid
Dr. Y.K. Hamied 65.59
Mr. M.K. Hamied 13.83
Ms. Samina Hamied 7.16
Mr. Umang Vohra 0.10
Mr. S.Radhakrishnan 0.08
Mr. Kedar Upadhye 0.02
86.78